Annual Total Liabilities
$317.20 M
+$129.80 M+69.27%
December 31, 2023
Summary
- As of February 23, 2025, ACAD annual total liabilities is $317.20 million, with the most recent change of +$129.80 million (+69.27%) on December 31, 2023.
- During the last 3 years, ACAD annual total liabilities has risen by +$161.59 million (+103.85%).
- ACAD annual total liabilities is now at all-time high.
Performance
ACAD Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$399.69 M
+$2.29 M+0.58%
September 30, 2024
Summary
- As of February 23, 2025, ACAD quarterly total liabilities is $399.69 million, with the most recent change of +$2.29 million (+0.58%) on September 30, 2024.
- Over the past year, ACAD quarterly total liabilities has stayed the same.
- ACAD quarterly total liabilities is now at all-time high.
Performance
ACAD Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ACAD Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +69.3% | 0.0% |
| 3 y3 years | +103.8% | +165.2% |
| 5 y5 years | +419.0% | +423.9% |
ACAD Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +99.2% | at high | +151.0% |
| 5 y | 5-year | at high | +277.4% | at high | +375.6% |
| alltime | all time | at high | +7642.3% | at high | +6467.3% |
ACADIA Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $399.69 M(+0.6%) |
| Jun 2024 | - | $397.40 M(+1.6%) |
| Mar 2024 | - | $391.06 M(+23.3%) |
| Dec 2023 | $317.20 M(+69.3%) | $317.20 M(+17.3%) |
| Sep 2023 | - | $270.37 M(+9.5%) |
| Jun 2023 | - | $246.98 M(-12.1%) |
| Mar 2023 | - | $281.05 M(+50.0%) |
| Dec 2022 | $187.40 M(+17.7%) | $187.40 M(+6.0%) |
| Sep 2022 | - | $176.81 M(-0.6%) |
| Jun 2022 | - | $177.92 M(-0.9%) |
| Mar 2022 | - | $179.45 M(+12.7%) |
| Dec 2021 | $159.23 M(+2.3%) | $159.23 M(+5.6%) |
| Sep 2021 | - | $150.72 M(-5.6%) |
| Jun 2021 | - | $159.59 M(-8.1%) |
| Mar 2021 | - | $173.57 M(+11.5%) |
| Dec 2020 | $155.61 M(+85.1%) | $155.61 M(+10.5%) |
| Sep 2020 | - | $140.80 M(+45.7%) |
| Jun 2020 | - | $96.64 M(-11.4%) |
| Mar 2020 | - | $109.07 M(+29.8%) |
| Dec 2019 | $84.05 M(+37.5%) | $84.05 M(+10.2%) |
| Sep 2019 | - | $76.30 M(+6.0%) |
| Jun 2019 | - | $71.97 M(-13.0%) |
| Mar 2019 | - | $82.75 M(+35.4%) |
| Dec 2018 | $61.12 M(+24.2%) | $61.12 M(+42.1%) |
| Sep 2018 | - | $43.02 M(-14.4%) |
| Jun 2018 | - | $50.24 M(+7.2%) |
| Mar 2018 | - | $46.87 M(-4.8%) |
| Dec 2017 | $49.22 M(+15.2%) | $49.22 M(+35.3%) |
| Sep 2017 | - | $36.39 M(-11.6%) |
| Jun 2017 | - | $41.17 M(-9.5%) |
| Mar 2017 | - | $45.49 M(+6.4%) |
| Dec 2016 | $42.74 M(+93.1%) | $42.74 M(+8.7%) |
| Sep 2016 | - | $39.33 M(+34.6%) |
| Jun 2016 | - | $29.22 M(+36.9%) |
| Mar 2016 | - | $21.34 M(-3.6%) |
| Dec 2015 | $22.13 M(+38.6%) | $22.13 M(+23.1%) |
| Sep 2015 | - | $17.97 M(-8.8%) |
| Jun 2015 | - | $19.72 M(+16.9%) |
| Mar 2015 | - | $16.87 M(+5.6%) |
| Dec 2014 | $15.97 M(+128.6%) | $15.97 M(+41.6%) |
| Sep 2014 | - | $11.27 M(+20.5%) |
| Jun 2014 | - | $9.36 M(+16.3%) |
| Mar 2014 | - | $8.05 M(+15.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2013 | $6.99 M(-70.4%) | $6.99 M(-62.3%) |
| Sep 2013 | - | $18.53 M(-27.1%) |
| Jun 2013 | - | $25.43 M(+8.9%) |
| Mar 2013 | - | $23.35 M(-1.1%) |
| Dec 2012 | $23.61 M(+169.7%) | $23.61 M(+287.9%) |
| Sep 2012 | - | $6.09 M(-33.6%) |
| Jun 2012 | - | $9.17 M(+2.6%) |
| Mar 2012 | - | $8.93 M(+2.1%) |
| Dec 2011 | $8.75 M(+0.5%) | $8.75 M(-1.4%) |
| Sep 2011 | - | $8.88 M(+4.6%) |
| Jun 2011 | - | $8.49 M(-3.3%) |
| Mar 2011 | - | $8.78 M(+0.8%) |
| Dec 2010 | $8.71 M(-76.8%) | $8.71 M(-75.8%) |
| Sep 2010 | - | $35.92 M(-0.2%) |
| Jun 2010 | - | $36.01 M(-0.5%) |
| Mar 2010 | - | $36.17 M(-3.7%) |
| Dec 2009 | $37.57 M(+221.5%) | $37.57 M(-4.9%) |
| Sep 2009 | - | $39.51 M(-9.5%) |
| Jun 2009 | - | $43.65 M(+264.2%) |
| Mar 2009 | - | $11.98 M(+2.6%) |
| Dec 2008 | $11.69 M(-43.4%) | $11.69 M(-2.3%) |
| Sep 2008 | - | $11.96 M(-19.6%) |
| Jun 2008 | - | $14.88 M(+1.5%) |
| Mar 2008 | - | $14.66 M(-29.0%) |
| Dec 2007 | $20.65 M(-7.8%) | $20.65 M(+10.9%) |
| Sep 2007 | - | $18.61 M(+16.7%) |
| Jun 2007 | - | $15.95 M(-15.8%) |
| Mar 2007 | - | $18.95 M(-15.3%) |
| Dec 2006 | $22.39 M(-3.2%) | $22.39 M(-0.6%) |
| Sep 2006 | - | $22.51 M(-16.7%) |
| Jun 2006 | - | $27.02 M(+14.2%) |
| Mar 2006 | - | $23.66 M(+2.3%) |
| Dec 2005 | $23.14 M(+138.9%) | $23.14 M(+9.8%) |
| Sep 2005 | - | $21.07 M(+68.8%) |
| Jun 2005 | - | $12.48 M(-7.9%) |
| Mar 2005 | - | $13.55 M(+39.9%) |
| Dec 2004 | $9.69 M(-88.5%) | $9.69 M(-6.8%) |
| Sep 2004 | - | $10.39 M(-1.2%) |
| Jun 2004 | - | $10.51 M(-87.8%) |
| Mar 2004 | - | $85.83 M(+1.7%) |
| Dec 2003 | $84.36 M(+50.3%) | $84.36 M |
| Dec 2002 | $56.11 M(+1269.6%) | - |
| Dec 2001 | $4.10 M(-92.8%) | - |
| Dec 2000 | $56.62 M | - |
FAQ
- What is ACADIA Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual total liabilities year-on-year change?
- What is ACADIA Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly total liabilities year-on-year change?
What is ACADIA Pharmaceuticals annual total liabilities?
The current annual total liabilities of ACAD is $317.20 M
What is the all time high annual total liabilities for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual total liabilities is $317.20 M
What is ACADIA Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, ACAD annual total liabilities has changed by +$129.80 M (+69.27%)
What is ACADIA Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ACAD is $399.69 M
What is the all time high quarterly total liabilities for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly total liabilities is $399.69 M
What is ACADIA Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, ACAD quarterly total liabilities has changed by $0.00 (0.00%)